Clinical Characterization and Outcomes of Dupilumab for Pemphigoid Gestationis: A Case Series of Five Patients and Literature Review
Joost M. Meijer, Elise J. Leeman, Dominika Grabik, Lisette M. Prens et autres
0 citationsActa Dermato Venereologica
Maria C. Bolling
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
119Publications signalées
3725Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Skin and Cellular Biology ResearchAutoimmune Bullous Skin DiseasesGenetic and rare skin diseases.Plant Reproductive BiologyWnt/β-catenin signaling in development and cancer
Publications récentes
VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome
Josefien J.L. van Leengoed, Abraham Rutgers, Karina de Leeuw, André B. Mulder et autres
0 citationsJAAD Case Reports
Classifying novel DSG1 variants on disease severity in SAM syndrome and palmoplantar keratoderma
Vanya S.V.J. Rossel, Jaap J. A. J. van der Velden, Renske Janssen, Bert Callewaert et autres
0 citationsJournal of Dermatological Science
271 Exploring the therapeutic effect of ablative Er:YAG laser therapy on Hailey-Hailey disease through transcriptomics
Marie-Eline P H Debeuf, Michel van Geel, Michiel Adriaens, Janou A. Y. Roubroeks et autres
0 citationsJournal of Investigative Dermatology
Bullous pemphigoid outcome measurement: a scoping review of outcome heterogeneity and trends in clinical research of treatments
Marjolein A J Hiel, Billal Tedbirt, Eva W H Korte, Maria C. Bolling et autres
2 citationsBritish Journal of Dermatology
Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab
Marjolein A J Hiel, Gilles F.H. Diercks, Maria C. Bolling, Jeroen Bremer et autres
2 citationsJAAD Case Reports
Core outcome domain sets for clinical trials in epidermolysis bullosa — a COSEB protocol to achieve consensus on “what” to measure
Eva W H Korte, Peter C. van den Akker, Dimitra Kiritsi, Jan Kottner et autres
0 citationsTrials
SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study
Clara Harrs, Maria C. Bolling, Peter C. van den Akker, Bart Koopman et autres
0 citationsJID Innovations
Mucous Membrane Pemphigoid Outcome Measurement in Clinical Research: A Scoping Review
Billal Tedbirt, Eva W H Korte, Marjolein A J Hiel, Joost M. Meijer et autres
0 citationsClinical Drug Investigation
Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey
Eva W H Korte, Marjolein A J Hiel, Maria C. Bolling, Patrick F. Dunn et autres
0 citationsBritish Journal of Dermatology
Neonatal Epidermolytic Ichthyosis Caused by a KRT10 Mutation (c.467G>A, p.Arg156His): A Case Report
Elke Smits, Gunnar Naulaers, Maria C. Bolling, Eric Legius et autres
1 citationClinical Case Reports
Recessive epidermolysis bullosa simplex due to EXPH5 variants: case series of a rare subtype with multiple faces
Laura A. Grutters, Rosalie Baardman, Jeroen Bremer, Duco Kramer et autres
0 citationsBritish Journal of Dermatology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.